We’re Building a Bridge to a World Without ALS
Every step, every story, and every gift brings us closer to the cure
Over 500,000 families are affected by ALS today
•
5,000 new cases diagnosed each year in the U.S. alone
•
ALS is a progressive neurodegenerative disease with no cure
•
Over 500,000 families are affected by ALS today • 5,000 new cases diagnosed each year in the U.S. alone • ALS is a progressive neurodegenerative disease with no cure •
Our Mission
The ALS Bridge Foundation’s mission is to accelerate the development of effective treatments for Amyotrophic Lateral Sclerosis (ALS) by providing crucial funding for early-stage drug trials and improving access to early diagnostics for individuals living with the disease in the United States and Canada. We are committed to bridging the gap between promising scientific research and tangible patient solutions, ultimately striving to create a future where ALS is a treatable condition.
Connecting people. Accelerating progress. Inspiring hope.
WHY WE EXIST
ALS is a devastating disease. It steals movement, speech, and independence while leaving the mind painfully aware. There is no cure, and most people diagnosed live only a few years.
Yet today, ALS research is at a tipping point — closer than ever to breakthroughs that could change everything. What’s missing is funding.
Because ALS is complex and underfunded, progress depends on philanthropy, not profit. That’s where The Bridge for ALS comes in — connecting patients, families, and researchers to fuel the discoveries that lead to cures.
Peter’s story
In August 2024, Peter Broome—a beloved leader in golf and retired Titleist executive—was diagnosed with ALS. Instead of retreating, he chose to rally. With his family, Peter created the ALS Bridge Foundation to unite the golf community and fund the fight against ALS. His goal is simple: turn passion into purpose, and every round into a chance to make a difference.
Golfers may be 300x more likely to develop ALS
•
Every 90 minutes, someone is diagnosed with ALS
•
Average survival after diagnosis is 2–5 years
•
Golfers may be 300x more likely to develop ALS • Every 90 minutes, someone is diagnosed with ALS • Average survival after diagnosis is 2–5 years •
Dr. Merit Cudkowicz, MD, MSC
Neurologist | Clinical Researcher
Executive Director, Mass General Brigham Neuroscience Institute
Director, Sean M. Healey & AMG Center for ALS Director and the Julieanne Dorn Professor of Neurology at Harvard Medical School
Why “The Bridge”?
The bridge has always been Peter’s symbol for connection and progress.
In his professional life, being called a bridge builder was the highest compliment — someone who leaves things stronger for those who follow. The ALS Bridge Foundation continues that legacy, connecting people, science, and solutions.
Turning Connection Into Action
Our mission is to direct the majority of funds to programs that accelerate ALS drug trials, improve patient access, and support innovative partnerships.
-
Expanding early trial access for patients.
-
Personalized treatment matching
Together, we’re creating the connection between compassion and cure
Join us in building the bridge. Every effort, big or small, brings us closer to the cure.